. 2016 Mar 22;24(5):946–955. doi: 10.1038/mt.2016.39
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
Table 1. Half-lives of miR-34a target mRNAs after treatment with miR-34a mimics in HeLa cells.
